Jennifer Wilcox
Family · Cookeville, TNNPI 1831653492
Payments from drug & device makers
Across 201 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$912
- AbbVie$479
- AstraZeneca$350
- Lilly USA, LLC$202
- Corcept Therapeutics$183
- Sumitomo Pharma America, Inc.$156
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,27499%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 54 | $912 |
| AbbVie | 37 | $479 |
| AstraZeneca(2 entities) | 18 | $350 |
| Lilly USA, LLC | 13 | $202 |
| Corcept Therapeutics | 11 | $183 |
| Sumitomo Pharma America, Inc. | 12 | $156 |
| Amgen | 6 | $104 |
| Neurocrine Biosciences, Inc. | 5 | $86 |
| GSK | 4 | $72 |
| Pfizer | 4 | $65 |
| Genentech USA, Inc. | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 2 | $51 |
| Exact Sciences | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Tempus AI, Inc | 2 | $41 |
| Insulet Corporation | 2 | $39 |
| Nevro Corp. | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $28 |
| Novartis | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Optos, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Merck | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $12 |
How this compares
$3,301 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 118 | $142,164 |
| MounjaroTirzepatide | 120 | $134,633 |
| JardianceEmpagliflozin | 119 | $133,277 |
| VraylarCariprazine Hcl | 43 | $65,270 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 83 | $59,854 |
| GemtesaVibegron | 81 | $57,193 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $56,579 |
| EliquisApixaban | 40 | $53,297 |
| TrulicityDulaglutide | 43 | $49,217 |
| UbrelvyUbrogepant | 14 | $23,759 |
| LinzessLinaclotide | 25 | $22,125 |
| Nurtec OdtRimegepant Sulfate | 13 | $22,118 |
| XareltoRivaroxaban | 26 | $16,357 |
| Repatha SureclickEvolocumab | 14 | $16,020 |
| FarxigaDapagliflozin Propanediol | 17 | $15,879 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $202 | $183,850163 claims |
| Novo NordiskOzempic | $912 | $142,164118 claims |
| Boehringer IngelheimJardiance | $15 | $133,277119 claims |
| AbbVieVraylar, Ubrelvy, Linzess | $479 | $111,15482 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $350 | $75,732100 claims |
| PfizerEliquis, Nurtec Odt | $65 | $75,41653 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $156 | $57,19381 claims |
| GSKTrelegy Ellipta | $72 | $56,57957 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $15 | $13,14411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Cookeville
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.